TSJCI Annual Report 2021

Trinity St James’s Cancer Institute Annual Report 2021 5 Critical to all we do is the recruitment and retention of top class staff. As outlined in the report we continue to expand our educational offerings, ranging from the establishment of the first national course in Fundamentals of Cancer Surgery to novel bursaries in Translational Cancer medicine. Fundraising in collaboration with Trinity Development and Alumni is focused also on recruitment and retention of staff of the highest quality. In conjunction with Trinity Development and Alumni (TDA) we anticipate being able to fund protected time for young investigators to pursue their research interests commencing in 2022. Professor Lorraine O’Driscoll was appointed research lead in 2021 and is supporting her colleagues in developing our four research themes. Some of the achievements of these groups are outlined in this report. Key to advancing our research agenda will be the appointment of several chairs in various cancer disciplines in the next 18 months. Plans for a number of these appointments have been advanced in 2021 in conjunction with the School of Medicine in TCD. As the first OECI (Organisation of European Cancer Institutes) accredited cancer center in Ireland we will be seeking recertification in 2024. We hope that the programme of continuous improvement in patient care, research, education and clinical trial activity outlined in this report will form the basis for successful re-accreditation, this time at the level of Comprehensive Cancer Center. This is the goal of the colleagues from a multiplicity of disciplines and services whose work is outlined in this report. Prof. John Kennedy Medical Director Trinity St James’s Cancer Institute Prof. Maeve Lowery Academic Director Trinity St James’s Cancer Institute